What one share of Ocugen holds
Ocugen is aiming to redefine the future of vision through game-changing gene therapies with the potential to address significant, unmet medical needs. Our First-in-class, breakthrough modifier gene therapy platform presents a potential paradigm shift in treating inherited retinal diseases and blindness diseases affecting millions across the globe.
Ocugen’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.01 |
|---|---|
| Profit | −$0.26 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.19 |
| Cash and investments | $0.30 |
| Debt | $0.01 |
| Book value | −$0.05 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | $0.00 | −$2.42 | $0.15 | −$2.42 | — | $2.12 |
| 2016 | $0.00 | −$2.18 | $0.02 | −$1.81 | — | $0.66 |
| 2017 | $0.00 | −$0.99 | $0.01 | −$1.03 | — | $0.18 |
| 2019 | $0.00 | −$1.46 | $0.00 | −$1.22 | — | — |
| 2020 | $0.00 | −$0.31 | $0.00 | −$0.13 | — | $0.12 |
| 2021 | $0.00 | −$0.30 | $0.00 | −$0.25 | — | $0.43 |
| 2022 | $0.01 | −$0.40 | $0.02 | −$0.30 | — | $0.32 |
| 2023 | $0.02 | −$0.26 | $0.04 | −$0.30 | — | $0.16 |
| 2024 | $0.01 | −$0.20 | $0.01 | −$0.17 | — | $0.10 |
| 2025 | $0.01 | −$0.23 | $0.00 | −$0.19 | — | −$0.04 |
Common questions about Ocugen
How much does one share of Ocugen earn?
Over the last 12 months, Ocugen lost $0.26 for each share on $0.01 of sales.
Does Ocugen pay a dividend?
Ocugen didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Ocugen’s book value per share?
Ocugen’s book value is negative (−$0.05 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Ocugen have?
Each share of Ocugen has $0.30 of cash and investments and $0.01 of debt, as of June 30, 2026.
What is Ocugen’s free cash flow per share?
−$0.19 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Ocugen bought back shares?
Ocugen’s share count rose about 2128% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.